Scancell (LON:SCLP) Trading Up 18.1% – Here’s What Happened

Scancell Holdings plc (LON:SCLP)’s stock price shot up 18.1% during trading on Monday . The company traded as high as GBX 11 ($0.15) and last traded at GBX 10.01 ($0.13). 3,712,693 shares traded hands during mid-day trading, an increase of 361% from the average session volume of 804,494 shares. The stock had previously closed at GBX 8.48 ($0.11).

Scancell Stock Performance

The stock has a market capitalization of £105.90 million, a P/E ratio of -15.68 and a beta of 0.35. The company has a debt-to-equity ratio of -566.79, a quick ratio of 13.01 and a current ratio of 3.42. The business’s fifty day moving average price is GBX 8.51 and its two-hundred day moving average price is GBX 10.85.

Scancell (LON:SCLP) last posted its quarterly earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share for the quarter. As a group, sell-side analysts forecast that Scancell Holdings plc will post -2.5361112 earnings per share for the current year.

Scancell Company Profile

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.